Galunisertib Active Not Recruiting Phase 1 Trials for Gliomas Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01682187A Dose-Escalation Study in Participants With Recurrent Malignant Glioma